PALVELLA THERAPEUTICS INC (PVLA) Stock Analyst Ratings
NASDAQ:PVLA - US6979471090 - Common Stock
55.28 USD
-0.4 (-0.72%)
ChartMill assigns a Buy % Consensus number of 82% to PVLA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 64. This target is 15.78% above the current price.
PVLA was analyzed by 18 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about PVLA.
In the previous month the buy percentage consensus was at a similar level.
PVLA was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-09 | Oppenheimer | Initiate | Outperform |
| 2025-08-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-06 | Raymond James | Initiate | Outperform |
| 2025-08-04 | LifeSci Capital | Initiate | Outperform |
| 2025-07-21 | Truist Securities | Initiate | Buy |
| 2025-05-16 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-09 | Chardan Capital | Initiate | Buy |
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-26 | Stifel | Initiate | Buy |
| 2025-03-25 | Jones Trading | Initiate | Buy |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2025-02-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-20 | Canaccord Genuity | Initiate | Buy |
| 2025-02-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-05 | TD Cowen | Initiate | Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-26 | HC Wainwright & Co. | Initiate | Buy |